3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
By Hailey Konnath
Apotex buys specialty pharma Searchlight in $500-million-plus move to diversify from generic drugs
By Sean Silcoff
Apotex, Heritage and Breckenridge settle with purchasers in generics price-fixing case
By Fraiser Kansteiner
Apotex' Aleve PM Rival Could Have 180-Day Exclusivity As A CGT
By Malcolm Spicer
FDA posts a flurry of voluntary drug recalls by Teva, Glenmark, Apotex and VistaPharm
By Joseph Keenan
Who Murdered Apotex Pharma Billionaire Barry Sherman and Honey?
By Ari Altstedter & Matthew Campbell
Apotex Sues to Clear Tradjenta Copy of Boehringer Patent Claims
By Christopher Yasiejko
A Broward company recalls a drug with an FDA black box warning about ‘suicidal thoughts’
By David J. Neal
Avenacy intros generic Alkeran
By Sandra Levy
Supernus settles patent litigation with Apotex over Oxtellar
By Jonathan Block, MPH
Troubled generics maker Apotex bought by SK Capital
By Kevin Dunleavy
The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls
By Kyle Blankenship
Apotex admits to generic price fixing, agrees to pay $24M criminal fine
By Eric Sagonowsky
Generic Drug Maker Admits to Fixing Prices for Cholesterol Medication (Published 2020)
By Katie Benner
Canadian Drugmaker Apotex May Revive Sale Talks and be Worth Billions
By Manuel Baigorri & Michelle Davis
Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs
By Zachary Brennan
After SK Capital buyout, Apotex yanks 6 batches of glaucoma med on sterility concerns
By Fraiser Kansteiner
Bayer, Meda sue Apotex over proposed Astepro Allergy generic
By Blake Brittain
UCB Wins Patent Order Blocking Copies of Briviact Epilepsy Drug
By Christopher Yasiejko
Federal Court dismisses action alleging patent infringement by new Apotex heartburn drug
By Karunjit Singh
A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success
By Kyle Blankenship
Apotex and Strides to merge their Australia businesses to become the country's largest generics player
By Eric Palmer
Apotex yanks ADHD med after traces of schizophrenia drug turn up in a single lot
By Fraiser Kansteiner
Doctrine of Equivalents in Lilly v. Apotex
By Dennis Crouch
Apotex pulls injectable anticoagulant batches after CMO's syringe mix-up
By Fraiser Kansteiner
Apotex Founder Barry Sherman Was Driven, Generous...and Litigious
By Vipal Monga & Jacquie McNish
Apotex recalls some Metformin batches due to possible carcinogen
By Angela Betsaida B. Laguipo
Canadian Drugmaker Apotex Is Said to Weigh Sale Amid Interest
By Vinicy Chan & Manuel Baigorri
Accused of stealing Teva secrets, Apotex CEO exits abruptly even as founder's death ruled homicide
By Eric Palmer
Gilead, J&J Sue Apotex to Block Copies of HIV Drug Symtuza
By Christopher Yasiejko
Horizon Sues Apotex to Block Early Launch of Pennsaid 2% Copy
By Christopher Yasiejko
U.K. cites Apotex plant in India; action comes in midst of probe into death of Apotex founder
By Eric Palmer
Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend
By Arlene Weintraub
The top 15 generic drugmakers by 2016 revenue
By Eric Sagonowsky
Scilex, Set to Go Public, Sues Apotex to Block ZTlido Copies (1)
By Christopher Yasiejko
Apotex Faces Uncertainty After Founder's Mysterious Death
By Vipal Monga & Jacquie McNish
FDA Adds Two Eye Drops to Its Recall List Due to Supply Chain Issues
By Veronica Salib